Atlas FDA

DEXCOM SEVEN AND SEVEN PLUS SYSTEM

FDA premarket approval P050012/S038 · decided 2011-08-12

Approval details

PMA number
P050012
Supplement
S038
Supplement type
30-Day Notice
Trade name
DEXCOM SEVEN AND SEVEN PLUS SYSTEM
Generic name
Sensor, glucose, invasive
Applicant
Dexcom, Inc.
Date received
2011-07-14
Decision date
2011-08-12
Days to decision
29 days
Decision code
OK30
Product code
MDS
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
REMOVAL OF REDUNDANT DEBURRING STEPS FROM THE CLEANING PROCESSES OF THE NEEDLE AND CANNULA COMPONENTS OF THE SEVEN AND SEVEN PLUS CONTINUOUS GLUCOSE MONITORING SYSTEMS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23